Literature DB >> 495692

Prostaglandin biosynthesis in pulmonary macrophages.

W Hsueh.   

Abstract

Cultured rabbit alveolar macrophages, prelabeled with 14C-arachidonic acid (AA), released into the medium a trace amount of labeled prostaglandins (PG) as well as their precursor, AA. Phagocytosis of zymosan, heat-killed Staphylococcus, or bacille Calmette-Guérin (BCG) increased the AA and PG release to 2--2.5 times control values. The released PGs consisted of PGE2, D2, F2 alpha, and 6-keto F1 alpha. Phagocytosis of latex particles had no effect on PG release. Indomethacin inhibited release of PGs but did not affect AA release at low doses. Analysis of the cellular lipids showed that zymosan decreased the radioactive label in phosphatidylcholine (PC), but not in other phospholipids or neutral lipids, suggesting that PC is the main source of AA for PG synthesis in pulmonary macrophages. Cytochalasin B (CB) at phagocytosis-inhibiting doses or below, markedly increased PG synthesis by zymosan-treated macrophages. These data suggest that PG release is not dependent on engulfment of the particles. Phagocytosis of zymosan (but not latex) also resulted in the release of two lysosomal enzymes, acid phosphatase and beta-glucuronidase, which appeared temporally associated with the release of PGs (but not to phagocytosis). Furthermore, CB augmented the zymosan-stimulated release of these enzymes at the same doses stimulating PG synthesis. However, indomethacin, at a dose completely inhibiting PG synthesis, failed to block lysosomal enzyme release. Thus, the coincidental release of PGs and lysosomal enzymes is not the result of a regulatory role of PGs in the release of lysosomal enzymes, but probably is the result of a common pathway of stimulation. (Am J Pathol 97:137--148, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495692      PMCID: PMC2042386     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Regulation of immunity and inflammation by mediators from macrophages.

Authors:  E R Unanue; D I Beller; J Calderon; J M Kiely; M J Stadecker
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

2.  The role of prostaglandins in the control of the immune response to an autologous red blood cell antigen (Hb).

Authors:  M Zimecki; D R Webb
Journal:  Clin Immunol Immunopathol       Date:  1977-11

3.  Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E.

Authors:  J I Kurland; R S Bockman; H E Broxmeyer; M A Moore
Journal:  Science       Date:  1978-02-03       Impact factor: 47.728

4.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

5.  Effect of indomethacin and related drugs on the calcium ion-dependent secretion of lysosomal and other enzymes by neutrophil polymorphonuclear leucocytes in vitro.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

6.  Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence.

Authors:  M J Weidemann; B A Peskar; K Wrogemann; E T Rietschel; H Staudinger; H Fischer
Journal:  FEBS Lett       Date:  1978-05-01       Impact factor: 4.124

7.  Metabolic patterns in three types of phagocytizing cells.

Authors:  R OREN; A E FARNHAM; K SAITO; E MILOFSKY; M L KARNOVSKY
Journal:  J Cell Biol       Date:  1963-06       Impact factor: 10.539

8.  Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors.

Authors:  J I Kurland; P W Kincade; M A Moore
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

9.  Elastase secretion by peritoneal exudative and alveolar macrophages.

Authors:  R White; H S Lin; C Kuhn
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  A histochemical study of phagocytic and enzymatic functions of rabbit mononuclear and polymorphonuclear exudate cells and alveolar macrophages. I. Survey and quantitation of enzymes, and states of cellular activation.

Authors:  A M DANNENBERG; M S BURSTONE; P C WALTER; J W KINSLEY
Journal:  J Cell Biol       Date:  1963-06       Impact factor: 10.539

View more
  6 in total

1.  Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages.

Authors:  C C Leslie; D M Detty
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

Review 2.  Mononuclear phagocytes and eicosanoids: aspects of their synthesis and biological activities.

Authors:  U F Schade; I Burmeister; E Elekes; R Engel; D T Wolter
Journal:  Blut       Date:  1989-12

3.  Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.

Authors:  J T Zakrzewski; N C Barnes; P J Piper; J F Costello
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

4.  Arachidonic acid metabolism in bovine alveolar macrophages. Effect of calcium ionophore on lipoxygenase products.

Authors:  S M Taylor; H D Liggitt; W W Laegreid; R Silflow; R W Leid
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

5.  Structural and biochemical changes in lungs of 3-methylindole-treated rats.

Authors:  L W Woods; D W Wilson; M J Schiedt; S N Giri
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

6.  Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.

Authors:  Kensaku Aihara; Tomohiro Handa; Toru Oga; Kizuku Watanabe; Kiminobu Tanizawa; Kohei Ikezoe; Yoshio Taguchi; Hiroe Sato; Kazuo Chin; Sonoko Nagai; Shuh Narumiya; Athol U Wells; Michiaki Mishima
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.